Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

1914 with DOI

2 strong · 14 moderate · 3 weak

Compilations

12026-04-26T05:03:54.183Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

31last ruled 2026-06-04

0 awaiting a ruling

Issued documents

62026-10-19T20:29:23.268Z

notice · info card · emergency

Searches

150 with no results

queries and counts on the build

Claims checked

6353 supported

53 supported · 10 not

Correspondence

0received

consent field ships in Phase 4

Edges

207

derivations recorded for this entity

Complete over 19 sources, 1 compilation, and 31 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/2c-i/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-10-19issueIssued notice
  4. 2026-09-24srcSynthesis of [13C6]-labelled phenethylamine derivatives for drug quantification in biological samples
  5. 2026-09-24srcPharmacology and Toxicology of N-Benzylphenethylamine (NBOMe) Hallucinogens
  6. 2026-09-24srcBehavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function
  7. 2026-09-24src2C or Not 2C: Phenethylamine Designer Drug Review
  8. 2026-09-24srcEffects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response
  9. 2026-09-24srcReceptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)
  10. 2026-09-24srcEffect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
  11. 2026-09-24srcToxicodynamic insights of 2C and NBOMe drugs - Is there abuse potential?
  12. 2026-09-24srcInvestigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists
  13. 2026-09-24srcIdentification of 5-HT2A receptor signaling pathways associated with psychedelic potential
  14. 2026-09-24srcMorbidity involving the hallucinogenic designer amines MDA and 2C-I
  15. 2026-09-24srcLegal highs: staying on top of the flood of novel psychoactive substances
  16. 2026-09-24srcPsychedelics and the human receptorome
  17. 2026-09-24srcNBOMes-Highly Potent and Toxic Alternatives of LSD
  18. 2026-09-24srcNew designer drug 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques
  19. 2026-09-24srcFunctional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors
  20. 2026-09-24srcIn vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding in rat brain membranes.
  21. 2026-09-24srcPiHKAL: A Chemical Love Story
  22. 2026-09-24src4-Iodo-2,5-Dimethoxyphenethylamine (2C-I) - DEA Drug & Chemical Evaluation
  23. 2026-09-04issueIssued emergency
  24. 2026-09-04issueIssued info_card
  25. 2026-09-04issueIssued notice
  26. 2026-06-04proposal29 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  27. 2026-06-04publicationPublication — backfill
  28. 2026-04-26revisionRevision 1
  29. 2026-04-26genGeneration — pipeline-v5pipeline-v5
  30. 2026-04-26rungeneration run

The same entries, as forms: six forms.